Neurobiology of Disease, 0969-9961

Tidskrift

Fler filtreringsmöjligheter
  1. 1997
  2. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease

    Anders Björklund, Carl Rosenblad, Christian Winkler & Deniz Kirik, 1997, I : Neurobiology of Disease. 4, 3-4, s. 186-200

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  3. 2001
  4. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of L-DOPA-induced dyskinesia

    P. A. Johansson, M. Andersson, K. E. Andersson & M. A. Cenci, 2001, I : Neurobiology of Disease. 8, 2, s. 220-239 20 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Alterations of Akt1 (PKBalpha) and p70(S6K) in transient focal ischemia

    S Janelidze, BIng-Ren Hu, P Siesjö & B K Siesjö, 2001 feb, I : Neurobiology of Disease. 8, 1, s. 147-154

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. 2002
  7. Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice.

    Åsa Petersén, Zoe Puschban, Julie Lotharius, B NicNiocaill, P Wiekop, W T O'Connor & Patrik Brundin, 2002, I : Neurobiology of Disease. 11, 1, s. 134-146

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats.

    Gunnar Andsberg, Zaal Kokaia, Ronald L Klein, Nicholas Muzyczka, Olle Lindvall & Ronald J Mandel, 2002, I : Neurobiology of Disease. 9, 2, s. 187-204

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2003
  10. Death mechanisms in status epilepticus-generated neurons and effects of additional seizures on their survival.

    Christine Ekdahl Clementson, Changlian Zhu, Sara Bonde, Ben A Bahr, Klas Blomgren & Olle Lindvall, 2003, I : Neurobiology of Disease. 14, 3, s. 513-523

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Kindling alters entorhinal cortex-hippocampal interaction by increased efficacy of presynaptic GABA(B) autoreceptors in layer III of the entorhinal cortex

    T Gloveli, J Behr, T Dugladze, Zaal Kokaia, Merab Kokaia & U Heinemann, 2003, I : Neurobiology of Disease. 13, 3, s. 203-212

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neurons

    KL O'Malley, J Liu, Julie Lotharius & W Holtz, 2003, I : Neurobiology of Disease. 14, 1, s. 43-51

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2004
  14. A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function.

    Martin Lundblad, B Picconi, Hanna Lindgren & Angela Cenci Nilsson, 2004, I : Neurobiology of Disease. 16, 1, s. 110-123

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy)

    N Stefanova, Martin Lundblad, F Tison, W Poewe, Angela Cenci Nilsson & GK Wenning, 2004, I : Neurobiology of Disease. 15, 3, s. 630-639

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Status epilepticus severity influences the long-term outcome of neurogenesis in the adult dentate gyrus.

    Paul Mohapel, Christine Ekdahl Clementson & Olle Lindvall, 2004, I : Neurobiology of Disease. 15, 2, s. 196-205

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

    C Konradi, Jenny Westin, Manolo Carta, ME Eaton, Katarzyna Kuter, A Dekundy, Martin Lundblad & Angela Cenci Nilsson, 2004, I : Neurobiology of Disease. 17, 2, s. 219-236

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. 2005
  19. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice

    T M Malm, M Koistinaho, M Parepalo, T Vatanen, Andreas Ooka, Stefan Karlsson & J Koistinahoa, 2005, I : Neurobiology of Disease. 18, 1, s. 134-142

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Cystatin C modulates neurodegeneration and neurogenesis following status epilepticus in mouse

    T J Pirttila, K Lukasiuk, Katarina Håkansson, Anders Grubb, Magnus Abrahamson & A Pitkanen, 2005, I : Neurobiology of Disease. 20, 2, s. 241-253

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.

    Ruben Smith, Åsa Petersén, Gillian P Bates, Patrik Brundin & Jia-Yi Li, 2005, I : Neurobiology of Disease. 20, 3, s. 673-684

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.

    David P D Woldbye, Avtandil Nanobashvili, Andreas Toft Sörensen, Henriette Husum, Tom G Bolwig, Gunnar Sørensen, Patrik Ernfors & Merab Kokaia, 2005, I : Neurobiology of Disease. 20, 3, s. 760-772

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.

    Joana Gil, Paul Mohapel, Ines Araujo, Natalija Popovic, Jia-Yi Li, Patrik Brundin & Åsa Petersén, 2005, I : Neurobiology of Disease. 20, 3, s. 744-751

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses

    Claudia G. Almeida, Davide Tampellini, Reisuke H. Takahashi, Paul Greengard, Michael T. Lin, Eric M. Snyder & Gunnar K. Gouras, 2005 nov, I : Neurobiology of Disease. 20, 2, s. 187-198

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. 2006
  26. Genetically determined susceptibility to neurodegeneration is associated with expression of inflammatory genes

    Maria Swanberg, Kristina Duvefelt, Margarita Diez, Jan Hillert, Tomas Olsson, Fredrik Piehl & Olle Lidman, 2006, I : Neurobiology of Disease. 24, 1, s. 67-88 22 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.

    Thomas Carlsson, Christian Winkler, Martin Lundblad, Angela Cenci Nilsson, Anders Björklund & Deniz Kirik, 2006, I : Neurobiology of Disease. 21, 3, s. 657-668

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Prostaglandin E(2) and BDNF levels in rat hippocampus are negatively correlated with status epilepticus severity: No impact on survival of seizure-generated neurons.

    Maria Antonietta Ajmone-Cat, Robert Iosif, Christine Ekdahl Clementson, Zaal Kokaia, Luisa Minghetti & Olle Lindvall, 2006, I : Neurobiology of Disease. 23, 1, s. 23-35

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.

    Emma Lane, C Winkler, Patrik Brundin & Angela Cenci Nilsson, 2006, I : Neurobiology of Disease. 22, 2, s. 334-345

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.

    Matthew Maingay, Marina Romero-Ramos, Manolo Carta & Deniz Kirik, 2006, I : Neurobiology of Disease. 23, 3, s. 522-532

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. 2007
  32. Nerve growth factor promotes survival of new neurons in the adult hippocampus.

    Helena Frielingsdorf, Daniel R Simpson, Leon J Thal & Donald P Pizzo, 2007, I : Neurobiology of Disease. 26, 1, s. 47-55

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline.

    Roland Månsson, Magnus Hansson, Saori Morota, Hiroyuki Uchino, Christine Ekdahl Clementson & Eskil Elmer, 2007, I : Neurobiology of Disease. 25, s. 198-205

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Soluble adhesion molecules and angiotensin-converting enzyme in dementia.

    Henrietta Nielsen, Elisabet Londos, Lennart Minthon & Sabina Janciauskiene, 2007, I : Neurobiology of Disease. 26, s. 27-35

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. Testicular degeneration in Huntington disease

    Jeremy M. Van Raamsdonk, Zoe Murphy, David M. Selva, Reza Hamidizadeh, Jacqueline Pearson, Åsa Petersén, Maria Björkqvist, Cameron Muir, Ian R. Mackenzie, Geoffrey L. Hammond, A. Wayne Vogl, Michael R. Hayden & Blair R. Leavitt, 2007, I : Neurobiology of Disease. 26, 3, s. 512-520

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. 2008
  37. Increased metabolism in the R6/2 mouse model of Huntington's disease.

    Jorien m van der Burg, Karl Bacos, Nigel I Wood, Andreas Lindqvist, Nils Wierup, Ben Woodman, Jaclyn Wamsteeker, Ruben Smith, Tomas Deierborg, Michael J Kuhar, Gillian P Bates, Hindrik Mulder, Charlotte Erlanson-Albertsson, Jennifer Morton, Patrik Brundin, Åsa Petersén & Maria Björkqvist, 2008, I : Neurobiology of Disease. 29, 1, s. 41-51

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. In vivo gene delivery to proliferating cells in the striatum generated in response to a 6-hydroxydopamine lesion of the nigro-striatal dopamine pathway

    Dwain Morris-Irvin, Deniz Kirik, Anders Björklund & Lachlan Thompson, 2008, I : Neurobiology of Disease. 30, 3, s. 343-352

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation

    B Picconi, V Paille, V Ghiglieri, V Bagetta, I Barone, Hanna Lindgren, G Bernardi, Angela Cenci Nilsson & P Calabresi, 2008, I : Neurobiology of Disease. 29, 2, s. 327-335

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.

    Emma Lane, Denis Soulet, L Vercammen, Angela Cenci Nilsson & Patrik Brundin, 2008, I : Neurobiology of Disease. 32, s. 220-228

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. 2009
  42. Increased levels of cocaine and amphetamine regulated transcript in two animal models of depression and anxiety.

    Sara Wiehager, Daniela I Beiderbeck, Susanne H M Gruber, Aram El-Khoury, Jackie Wamsteeker, Inga D Neumann, Åsa Petersén & Aleksander A Mathé, 2009, I : Neurobiology of Disease. 34, s. 375-380

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. 2010
  44. A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys.

    Daniella Rylander, Hanna Iderberg, Qin Li, Andrzej Dekundy, Jinlan Zhang, Hao Li, Ren Baishen, Wojciech Danysz, Erwan Bezard & Angela Cenci Nilsson, 2010, I : Neurobiology of Disease. 39, s. 352-361

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis.

    Charlotte Soneson, Magnus Fontes, Yongxia Zhou, Vladimir Denisov, Jane S Paulsen, Deniz Kirik & Åsa Petersén, 2010, I : Neurobiology of Disease. 40, s. 531-543

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. 2011
  47. Apoptosis-inducing factor mediates dopaminergic cell death in response to lps-induced inflammatory stimulus Evidence in Parkinson's disease patients.

    Miguel Burguillos Garcia, N Hajji, E Englund, A Persson, Angela Cenci Nilsson, A Machado, J Cano, B Joseph & J L Venero, 2011, I : Neurobiology of Disease. 41, s. 177-188

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. Cleavage of the vesicular glutamate transporters under excitotoxic conditions

    Andrea C. Lobo, Joao R. Gomes, Tatiana Catarino, Miranda Mele, Pedro Fernandez, Ana Inacio, Ben A. Bahr, Armanda E. Santos, Tadeusz Wieloch, Ana Luisa Carvalho & Carlos B. Duarte, 2011, I : Neurobiology of Disease. 44, 3, s. 292-303

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice.

    Jorien m van der Burg, Annika Winqvist, N Ahmad Aziz, Marion L C Maat-Schieman, Raymund A C Roos, Gillian P Bates, Patrik Brundin, Maria Björkqvist & Nils Wierup, 2011, I : Neurobiology of Disease. 44, s. 1-8

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.

    Veronica Francardo, Alessandra Recchia, Nataljia Popovic, Daniel Andersson, Hans Nissbrandt & Angela Cenci Nilsson, 2011, I : Neurobiology of Disease. 42, s. 327-340

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. 2012
  52. Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures

    Casper R. Gotzsche, Litsa Nikitidou, Andreas Toft Sörensen, Mikkel V. Olesen, Gunnar Sorensen, Soren H. O. Christiansen, Mikael Ängehagen, David P. D. Woldbye & Merab Kokaia, 2012, I : Neurobiology of Disease. 45, 1, s. 288-296

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. Dysregulated dopamine storage increases the vulnerability to alpha-synuclein in nigral neurons

    Ayse Ulusoy, Tomas Björklund, Kerstin Buck & Deniz Kirik, 2012, I : Neurobiology of Disease. 47, 3, s. 367-377

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  54. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to l-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels

    Flora Mela, Matteo Marti, Simone Bido, Angela Cenci Nilsson & Michele Morari, 2012, I : Neurobiology of Disease. 45, 1, s. 573-582

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain

    Erik Cederfjäll, Gurdal Sahin & Deniz Kirik, 2012, I : Neurobiology of Disease. 48, 2, s. 222-227

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  56. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.

    Mickael Decressac, Bengt Mattsson, Martin Lundblad, P Weikop & Anders Björklund, 2012, I : Neurobiology of Disease. 45, 3, s. 939-953

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  57. Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.

    Eunju Shin, Joanna Garcia, Christian Winkler, Anders Björklund & Manolo Carta, 2012, I : Neurobiology of Disease. 47, 3, s. 393-406

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  58. Special Issue: Viral delivery of genes: new frontiers Introduction

    Jeffrey H. Kordower & Deniz Kirik, 2012, I : Neurobiology of Disease. 48, 2, s. 151-152

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

Föregående 1 2 Nästa